{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:29:13Z","timestamp":1793946553055,"version":"4.8.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004387","name":"Ningbo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.critrevonc.2026.105501","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:39:44Z","timestamp":1785220784000},"page":"105501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Application of mRNA vaccines in head and neck cancer immunotherapy: Current progress and challenges"],"prefix":"10.1016","volume":"226","author":[{"given":"Linrong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhounan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105501_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1596583","article-title":"Advances and challenges in immunotherapy in head and neck cancer","volume":"16","author":"Aboaid","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib2","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.3390\/cancers17233817","article-title":"Emerging and Investigational Systemic Therapies in Recurrent\/Metastatic Head and Neck Cancer After Progression on Immunotherapy","volume":"17","author":"Abraham","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105501_bib3","unstructured":"Artificial intelligence-driven circRNA vaccine development: multimodal collaborative optimization and a new paradigm for biomedical applications - PubMed [WWW Document], n.d. URL https:\/\/pubmed.ncbi.nlm.nih.gov\/40483546\/ (accessed 5.17.26)."},{"key":"10.1016\/j.critrevonc.2026.105501_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jormas.2025.102265","article-title":"NKAP: A new m6A RNA binding protein predicts prognosis and immunotherapy response in head and neck squamous cell carcinoma","volume":"126","author":"Arumugam","year":"2025","journal-title":"J. Stomatol. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.critrevonc.2026.105501_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/hed.70077","article-title":"A Real-World Phase IV Superiority Trial and Cost-Effectiveness Analysis of the Addition of Low-Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the Paclitaxel Carboplatin Regimen in Recurrent or Metastatic Head and Neck Cancer Patients","volume":"48","author":"Khadela","year":"2026","journal-title":"Head. Neck"},{"key":"10.1016\/j.critrevonc.2026.105501_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40265-023-01835-2","article-title":"Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update","volume":"83","author":"Bhatia","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.critrevonc.2026.105501_bib7","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1016\/j.vaccine.2020.04.049","article-title":"Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas","volume":"38","author":"Bzhalava","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.critrevonc.2026.105501_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1458884","article-title":"Role of N6-methyladenosine methylation in head and neck cancer and its regulation of innate immune pathways","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/cancers15030852","article-title":"Head and Neck Cancer Immunotherapy: Molecular Biological Aspects of Preclinical and Clinical Research","volume":"15","author":"Chakraborty","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105501_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7150\/thno.89247","article-title":"Path towards mRNA delivery for cancer immunotherapy from bench to bedside","volume":"14","author":"Chen","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105501_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1064754","article-title":"Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40425-019-0662-5","article-title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)","volume":"7","author":"Cohen","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105501_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biomaterials.2018.12.019","article-title":"Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation","volume":"195","author":"Coolen","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105501_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.46883\/ONC.2021.3504.0190","article-title":"Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy","volume":"35","author":"Copur","year":"2021","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2026.105501_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1021609","article-title":"The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy","volume":"12","author":"Damasio","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3390\/genes12030422","article-title":"Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets","volume":"12","author":"Dlamini","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.critrevonc.2026.105501_bib17","unstructured":"Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteria - PubMed [WWW Document], n.d. URL https:\/\/pubmed.ncbi.nlm.nih.gov\/33079405\/ (accessed 5.17.26)."},{"key":"10.1016\/j.critrevonc.2026.105501_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103679","article-title":"Immunotherapy for head and neck cancer: Present and future","volume":"174","author":"Fasano","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010569","article-title":"Leveraging mRNA technology for antigen based immuno-oncology therapies","volume":"13","author":"Floudas","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105501_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1256105","article-title":"The identification of tumor antigens and immune subtypes based on the development of immunotherapies targeting head and neck squamous cell carcinomas resulting from periodontal disease","volume":"13","author":"Fu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1517\/14728214.2010.497754","article-title":"Emerging drugs to treat squamous cell carcinomas of the head and neck","volume":"15","author":"Fung","year":"2010","journal-title":"Expert. Opin. Emerg. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105501_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1517\/14728214.2010.497754","article-title":"Emerging drugs to treat squamous cell carcinomas of the head and neck","volume":"15","author":"Fung","year":"2010","journal-title":"Expert. Opin. Emerg. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105501_bib23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/vaccines10081272","article-title":"Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects","volume":"10","author":"Gao","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.critrevonc.2026.105501_bib24","article-title":"Head and Neck Cancer Immunotherapy: Overcoming Limitations and Enhancing Efficacy","volume":"116","author":"H, S","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2026.105501_bib25","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.21037\/tcr-20-2096","article-title":"Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review","volume":"10","author":"Hayman","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105501_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70075","article-title":"Synergy Effects of HPV E6-E7 Encoding mRNA and Nucleic Acid Immunostimulators Improve Therapeutic Potential in TC-1 Graft Tumor","volume":"96","author":"He","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/0022034519864112","article-title":"Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade","volume":"98","author":"Heath","year":"2019","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.critrevonc.2026.105501_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12967-025-06344-2","article-title":"A strategy for synergistic enhancement of immune circulation in head and neck squamous cell carcinoma by novel nucleic acid drug therapy and immunotherapy","volume":"23","author":"Hong","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105501_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13659-024-00432-4","article-title":"Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease","volume":"14","author":"Hu","year":"2024","journal-title":"Nat. Prod. Bioprospect"},{"key":"10.1016\/j.critrevonc.2026.105501_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccmp.2023.100089","article-title":"Emergency Protective Measures and Strategies of COVID-19: From Lifestyle to Traditional Chinese Medicine","volume":"3","author":"Hu","year":"2023","journal-title":"Clin. Complement. Med. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib31","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/eurheartj\/ehy293","article-title":"Grants supporting research in China","volume":"39","author":"Hu","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.critrevonc.2026.105501_bib32","article-title":"Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer","volume":"14","author":"Hu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib33","first-page":"641","article-title":"Immunocheckpoint inhibition in head and neck squamous cell carcinoma: the current status and progress]","volume":"41","author":"Huang","year":"2019","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.critrevonc.2026.105501_bib34","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1097\/CM9.0000000000003455","article-title":"mRNA vaccines as cancer therapies","volume":"137","author":"Huang","year":"2024","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.critrevonc.2026.105501_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.592319","article-title":"Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review","volume":"11","author":"Hui","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib36","article-title":"Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy","volume":"14","author":"Imani","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcyt.2021.08.005","article-title":"Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials","volume":"24","author":"Ingels","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.critrevonc.2026.105501_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/pcmedi\/pbae017","article-title":"Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology","volume":"7","author":"Jacob","year":"2024","journal-title":"Precis. Clin. Med."},{"key":"10.1016\/j.critrevonc.2026.105501_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4103\/0019-509X.204786","article-title":"Current status of systemic therapy for recurrent and\/or metastatic squamous cell carcinoma of the head and neck","volume":"53","author":"Jacob","year":"2016","journal-title":"Indian. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105501_bib40","article-title":"GPC3-based circular RNA vaccine suppresses hepatocellular carcinoma progression by activating adaptive immune responses","author":"Jiang","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2026.105501_bib41","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S1470-2045(19)30306-7","article-title":"Radioimmunotherapy for the treatment of head and neck cancer","volume":"20","author":"Karam","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2302\/kjm.71-001-ABST","article-title":"Developing mRNA for Therapy","volume":"71","author":"Karik\u00f3","year":"2022","journal-title":"Keio J. Med."},{"key":"10.1016\/j.critrevonc.2026.105501_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221150559","article-title":"Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects","volume":"22","author":"Khadela","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105501_bib44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/ijms22010240","article-title":"Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma","volume":"22","author":"Kitamura","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105501_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s43046-026-00356-9","article-title":"A real-world study of the effectiveness and safety of low-dose immunotherapy in addition to oral metronomic chemotherapy in recurrent and metastatic head and neck squamous cell carcinoma","volume":"38","author":"Kothari","year":"2026","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2026.105501_bib46","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1080\/14656566.2021.1948011","article-title":"Advances in pharmacotherapy for head and neck cancer","volume":"22","author":"Kumar","year":"2021","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105501_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127766","article-title":"Effective mRNA-based therapy using E7 antigen and IL-12 cytokine in head and neck cancer mice models","volume":"64","author":"Lee","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.critrevonc.2026.105501_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217752","article-title":"Cancer mRNA vaccines: clinical application progress and challenges","volume":"625","author":"Li","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105501_bib49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/biom13010090","article-title":"Screening of Tumor Antigens and Construction of Immune Subtypes for mRNA Vaccine Development in Head and Neck Squamous Cell Carcinoma","volume":"13","author":"Li","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2026.105501_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12032-025-03183-5","article-title":"Progress in immunotherapy for resectable head and neck squamous cell carcinoma","volume":"43","author":"Li","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.140930","article-title":"Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines","volume":"456","author":"Li","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.critrevonc.2026.105501_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189068","article-title":"Advances and prospects of mRNA vaccines in cancer immunotherapy","volume":"1879","author":"Liu","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105501_bib53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.otc.2025.08.009","article-title":"Novel Treatment Approaches in Recurrent\/Metastatic Squamous Head and Neck Cancer","volume":"59","author":"Llop","year":"2026","journal-title":"Otolaryngol. Clin. North. Am."},{"key":"10.1016\/j.critrevonc.2026.105501_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145501","article-title":"Advancing mRNA vaccines: A comprehensive review of design, delivery, and efficacy in infectious diseases","volume":"319","author":"Lu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/794528","article-title":"RNA-Based Vaccines in Cancer Immunotherapy","volume":"2015","author":"McNamara","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105501_bib56","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1097\/MS9.0000000000004174","article-title":"Messenger RNA vaccines as adjuncts to surgical oncology: a new era in neoplasm immunotherapy and precision medicine","volume":"87","author":"Mehmood","year":"2025","journal-title":"Ann. Med. Surg. (Lond. )"},{"key":"10.1016\/j.critrevonc.2026.105501_bib57","doi-asserted-by":"crossref","first-page":"9215","DOI":"10.3390\/cimb45110577","article-title":"Head and Neck Squamous Cell Carcinoma Vaccine: Current Landscape and Perspectives","volume":"45","author":"Meliante","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib58","article-title":"mRNA aggregates harness danger response for potent cancer immunotherapy","author":"Mendez-Gomez","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.critrevonc.2026.105501_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116095","article-title":"The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers","volume":"171","author":"Mestiri","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105501_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105501_bib61","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.12669\/pjms.40.7.8791","article-title":"Vaccine a promising immunotherapy option for head and neck cancer patients","volume":"40","author":"Mohsin","year":"2024","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105501_bib62","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s40265-017-0734-0","article-title":"Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies","volume":"77","author":"Moreira","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.critrevonc.2026.105501_bib63","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1586\/erv.13.23","article-title":"Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer","volume":"12","author":"Morrow","year":"2013","journal-title":"Expert. Rev. Vaccin."},{"key":"10.1016\/j.critrevonc.2026.105501_bib64","first-page":"617","article-title":"Immunotherapeutic Approaches to the Management of Head and Neck Cancer","volume":"32","author":"Nan","year":"2018","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2026.105501_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.128059","article-title":"Evolution and trends in non-viral mRNA Cancer vaccines: A scoping review from 2015 to 2025","volume":"71","author":"Nowzari","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.critrevonc.2026.105501_bib66","doi-asserted-by":"crossref","first-page":"11695","DOI":"10.3390\/ijms241411695","article-title":"Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer","volume":"24","author":"O\u2019Meara","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105501_bib67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/CJI.0000000000000075","article-title":"Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors","volume":"38","author":"Osada","year":"2015","journal-title":"J. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105501_bib68","article-title":"Immunotherapy in head and neck squamous cell carcinoma: An updated review","volume":"33","author":"Parmar","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105501_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202311574","article-title":"Supramolecular Lipid Nanoparticles Based on Host-Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy","volume":"36","author":"Qi","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.critrevonc.2026.105501_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102780","article-title":"mRNA-LNP vaccination orchestrates systemic immunity to control human papillomavirus-positive head and neck squamous cell carcinoma","volume":"36","author":"Qiu","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.critrevonc.2026.105501_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.105068","article-title":"The role of therapeutic cancer vaccines in the modern immunotherapy era: State of the art with recent progress and future challenges","volume":"217","author":"Rota","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib72","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3390\/biomedicines11082097","article-title":"Combining Radiotherapy and Immunotherapy in Head and Neck Cancer","volume":"11","author":"Runnels","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2026.105501_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1445191","article-title":"Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review","volume":"14","author":"Sanwick","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib74","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1158\/1078-0432.CCR-13-2617","article-title":"Phase I dendritic cell p53 peptide vaccine for head and neck cancer","volume":"20","author":"Schuler","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105501_bib75","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00106-024-01525-9","article-title":"[Update on HPV-associated head and neck cancers-highlights of the 2024 ASCO Annual Meeting]","volume":"72","author":"Sharma","year":"2024","journal-title":"HNO"},{"key":"10.1016\/j.critrevonc.2026.105501_bib76","article-title":"Hybrid mRNA Nano Vaccine Potentiates Antigenic Peptide Presentation and Dendritic Cell Maturation for Effective Cancer Vaccine Therapy and Enhances Response to Immune Checkpoint Blockade","volume":"12","author":"Shi","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.critrevonc.2026.105501_bib77","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6074.TUMIMM18-B83","article-title":"RNA-nanoparticles for immunotherapy-resistant head and neck squamous cell carcinoma","author":"Silver","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105501_bib78","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.AACRAHNS19-A18","article-title":"Personalized RNA nanoparticles remodel the HNSCC immunologic milieu to unlock immunotherapeutic activity","author":"Silver","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105501_bib79","first-page":"315","article-title":"[The research progress of PD-1\/L1 inhibitors application in the treatment of head and neck squamous cell carcinoma]","volume":"36","author":"Song","year":"2022","journal-title":"Lin. Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10.1016\/j.critrevonc.2026.105501_bib80","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MOO.0000000000000700","article-title":"Immunotherapy for head and neck cancer: from recurrent\/metastatic disease to (neo)adjuvant treatment in surgically resectable tumors","volume":"29","author":"Specenier","year":"2021","journal-title":"Curr. Opin. Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.critrevonc.2026.105501_bib81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10989-021-10334-5","article-title":"Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines","volume":"28","author":"Sun","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.critrevonc.2026.105501_bib82","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1097\/MS9.0000000000004234","article-title":"Toward cancer immunoprevention: what are the prospects for therapeutic vaccines?","volume":"87","author":"Tague","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.critrevonc.2026.105501_bib83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41420-024-01842-6","article-title":"NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma","volume":"10","author":"Topchu","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.critrevonc.2026.105501_bib84","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jjco\/hyaf199","article-title":"Technological advances in mRNA delivery and engineering for therapeutic cancer vaccines","volume":"56","author":"Uchida","year":"2026","journal-title":"Jpn J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib85","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002350","article-title":"Cancer vaccines: advances, hurdles, and future directions","volume":"6","author":"Vlachostergios","year":"2025","journal-title":"Explor. Target. Antitumor Ther."},{"key":"10.1016\/j.critrevonc.2026.105501_bib86","article-title":"Immunotherapy Advances in Locally Advanced and Recurrent\/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib87","article-title":"Bibliometric study on the knowledge graph of immunotherapy for head and neck cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib88","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.3390\/v14122824","article-title":"Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer","volume":"14","author":"Xu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.critrevonc.2026.105501_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.70041","article-title":"mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics","volume":"4","author":"Yang","year":"2025","journal-title":"Cancer Innov."},{"key":"10.1016\/j.critrevonc.2026.105501_bib90","first-page":"438","article-title":"Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics","volume":"23","author":"Yang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.critrevonc.2026.105501_bib91","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/acs.nanolett.0c05039","article-title":"Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy","volume":"21","author":"Yin","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.critrevonc.2026.105501_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.941750","article-title":"Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma","volume":"10","author":"Yu","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106002","article-title":"The biology of combination immunotherapy in recurrent metastatic head and neck cancer","volume":"136","author":"Yuan","year":"2021","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105501_bib94","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1097\/MS9.0000000000003002","article-title":"Exploring the potential of CAR-NK cell therapy in the management of head and neck cancer (HNC): a narrative review","volume":"87","author":"Zare","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.critrevonc.2026.105501_bib95","article-title":"Identification of ferroptosis-associated tumor antigens as the potential targets to prevent head and neck squamous cell carcinoma","volume":"11","author":"Zhai","year":"2024","journal-title":"Genes. Dis."},{"key":"10.1016\/j.critrevonc.2026.105501_bib96","article-title":"Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105501_bib97","article-title":"Advances and Strategies in Enhancing mRNA Cancer Vaccines","volume":"37","author":"Zhang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.critrevonc.2026.105501_bib98","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012090","article-title":"mRNA-encoded mutant HPV16\/18 vaccines promote specific T-cell responses and synergize with anti-PD-1 checkpoint blockade in mediating therapeutic tumor regression in mice","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105501_bib99","article-title":"Unraveling the immune evasion mechanisms in the tumor microenvironment of head and neck squamous cell carcinoma","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Immunol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:46:38Z","timestamp":1793943998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":99,"alternative-id":["S1040842826003884"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105501","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of mRNA vaccines in head and neck cancer immunotherapy: Current progress and challenges","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105501"}}